AssetMark Inc
IBB icon

AssetMark Inc’s iShares Biotechnology ETF IBB Stock Holding History

AssetMark Inc’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13M Buy
76,710
+2,681
+4% +$458K 0.03% 442
2025
Q4 		$12.5M Buy
74,029
+73,980
+150,980% +$12M 0.03% 440
2025
Q3 		$7.07K Buy
49
+6
+14% +$819 ﹤0.01% 2232
2025
Q2 		$5.44K Sell
43
-63
-59% -$7.73K ﹤0.01% 2114
2025
Q1 		$13.6K Sell
106
-74
-41% -$10K ﹤0.01% 1783
2024
Q4 		$23.8K Buy
+180
New +$25.3K ﹤0.01% 1613
2022
Q4 		– Sell
-51
Closed -$6K – 1618
2022
Q3 		$6K Buy
51
+26
+104% +$3.23K ﹤0.01% 1274
2022
Q2 		$3K Buy
+25
New +$2.97K ﹤0.01% 1344
2021
Q2 		– Sell
-67
Closed -$10K – 1421
2021
Q1 		$10K Buy
67
+65
+3,250% +$10.3K ﹤0.01% 930
2020
Q4 		$0 Sell
2
-148
-99% -$21.2K ﹤0.01% 1430
2020
Q3 		$20K Hold
150
– – ﹤0.01% 835
2020
Q2 		$21K Hold
150
– – ﹤0.01% 790
2020
Q1 		$16K Buy
+150
New +$17.3K ﹤0.01% 911
2017
Q4 		– Sell
-21
Closed -$2K – 1987
2017
Q3 		$2K Hold
21
– – ﹤0.01% 1270
2017
Q2 		$2K Hold
21
– – ﹤0.01% 1222
2017
Q1 		$2K Hold
21
– – ﹤0.01% 1134
2016
Q4 		$2K Hold
21
– – ﹤0.01% 1135
2016
Q3 		$2K Sell
21
-147
-88% -$14K ﹤0.01% 1122
2016
Q2 		$14K Sell
168
-465
-73% -$41.7K ﹤0.01% 917
2016
Q1 		$55K Sell
633
-670,257
-100% -$59.9M ﹤0.01% 546
2015
Q4 		$75.7M Sell
670,890
-300,225
-31% -$32.6M 1.4% 18
2015
Q3 		$98.2M Buy
971,115
+440,313
+83% +$52.8M 2.05% 13
2015
Q2 		$65.3M Sell
530,802
-183,762
-26% -$22M 1.36% 22
2015
Q1 		$81.8M Buy
714,564
+316,104
+79% +$34.9M 1.74% 15
2014
Q4 		$40.3M Buy
+398,460
New +$38.7M 0.88% 34
2014
Q3 		– Sell
-23,748
Closed -$2.04M – 486
2014
Q2 		$2.04M Buy
+23,748
New +$1.87M 0.04% 200

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc's IBB Position: Q1 2026 in Review

AssetMark Inc increased its iShares Biotechnology ETF (IBB) stake by 3.6% in Q1 2026, buying an estimated $458K and bringing the position to 76,710 shares worth $13M. The position accounts for 0.03% of the portfolio, ranked #442.

AssetMark Inc first reported a position in IBB in Q2 2014 and has held it in 26 quarters since. The position peaked at $98.2M in Q3 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • AssetMark Inc held 76,710 shares of iShares Biotechnology ETF worth $13M as of Q1 2026.
  • AssetMark Inc bought 2,681 iShares Biotechnology ETF shares in Q1 2026, an estimated $458K.
  • iShares Biotechnology ETF made up 0.03% of AssetMark Inc's portfolio in Q1 2026, its #442 holding.
  • AssetMark Inc first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 26 quarters since.
  • AssetMark Inc's iShares Biotechnology ETF position peaked at $98.2M in Q3 2015.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.